JINYU BIO-TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.14 CNY | +2.24% |
|
+2.58% | -15.13% |
| Apr. 25 | Jinyu Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 27 | Taihe Technologies' Chief Financial Officer Resigns | MT |
| Sales 2023 | 1.6B 221M | Sales 2024 * | 1.85B 255M | Capitalization | 9.94B 1.37B |
|---|---|---|---|---|---|
| Net income 2023 | 284M 39.22M | Net income 2024 * | 363M 50.13M | EV / Sales 2023 | 6.26 x |
| Net cash position 2023 | 1.71B 236M | Net cash position 2024 * | 1.73B 239M | EV / Sales 2024 * | 4.44 x |
| P/E ratio 2023 |
41.4
x | P/E ratio 2024 * |
28
x | Employees | 1,618 |
| Yield 2023 |
0.74% | Yield 2024 * |
1.06% | Free-Float | 80.2% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.24% | ||
| 1 week | +2.58% | ||
| 1 month | -3.89% | ||
| 3 months | +18.55% | ||
| 6 months | -2.97% | ||
| Current year | -15.13% |
1 week
8.88
9.18
1 month
8.659.66
Current year
6.9410.93
1 year
6.9411.59
3 years
6.9422.10
5 years
6.9431.15
10 years
6.9431.15
| Managers | Title | Age | Since |
|---|---|---|---|
Min Peng
DFI | Director of Finance/CFO | 38 | 21-04-30 |
Jing Zhang
PSD | President | 41 | - |
Yi Kun Liu
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhen Ping Wu
BRD | Director/Board Member | 56 | 22-05-30 |
Chong Yu Zhang
CHM | Chairman | 70 | 04-05-26 |
Chang E Shen
BRD | Director/Board Member | 61 | 19-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.67% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 9.14 | +2.24% | 20,475,070 |
| 24-04-29 | 8.94 | +0.34% | 20,200,130 |
| 24-04-26 | 8.91 | -2.20% | 18,858,440 |
| 24-04-25 | 9.11 | -0.87% | 9,744,500 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy products.
Sector
Pharmaceuticals
Calendar
2024-05-27
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
9.14
CNY
Average target price
9.38
CNY
Spread / Average Target
+2.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.13% | 1.37B | |
| -9.19% | 6.67B | |
| +24.75% | 3.7B | |
| -1.11% | 3.21B | |
| +6.08% | 1.52B | |
| -25.63% | 1.24B | |
| -7.62% | 1.21B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B | |
| -7.07% | 832M |
- Stock Market
- Equities
- 600201 Stock
